Lowering Risk Factors through Cholesterol Treatment: Overview of the Recent Major TrialsBySidney C. Smith, Jr, MDSeptember 1st 1997
Preventing Coronary Heart Disease in the Managed Care Era: Improving the Cost Effectiveness of Lipid-Lowering Therapy with HMG-CoA Reductase InhibitorsByTerry A. Jacobson, MDSeptember 1st 1997
Treating Hyperlipidemia to Prevent Coronary Heart Disease: What Are the Treatment Goals and How Do We Get There?ByChristie M. Ballantyne, MDSeptember 1st 1997
